Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L L Simpson

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Annals of the New York Academy of Sciences|January 1, 1983
Animals and animal tissues in the discipline of pharmacologyL L Simpson
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1982
The interaction between aminoquinolines and presynaptically acting neurotoxinsL L Simpson
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1982
A comparison of the pharmacological properties of Clostridium botulinum type C1 and C2 toxinsL L Simpson
Neuropharmacology|August 1, 1974
Studies on the binding of botulinum toxin type A to the rat phrenic nerve-hemidiaphragm preparationL L Simpson
Journal of Neurochemistry|February 1, 1972
The use of phospholipase C in the study of receptors for neuromuscular blocking agentsL L Simpson
The American Journal of Psychiatry|November 1, 1979
Combined use of molindone and guanethidine in patients with schizophrenia and hypertensionL L Simpson
Advances in Cytopharmacology|January 1, 1979
Studies on the mechanism of action of botulinum toxinL L Simpson
Biochemical Pharmacology|January 1, 1978
Evidence that deprenyl, A type B monoamine oxidase inhibitor, is an indirectly acting sympathomimetic amineL L Simpson
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1978
Mechanism of the adverse interaction between monoamine oxidase inhibitors and amphetamineL L Simpson
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1975
An analysis of the sympathomimetic activity of 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (TIQ)L L Simpson
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Annals of the New York Academy of Sciences|January 1, 1983
Animals and animal tissues in the discipline of pharmacologyL L Simpson
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1982
The interaction between aminoquinolines and presynaptically acting neurotoxinsL L Simpson
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1982
A comparison of the pharmacological properties of Clostridium botulinum type C1 and C2 toxinsL L Simpson
Neuropharmacology|August 1, 1974
Studies on the binding of botulinum toxin type A to the rat phrenic nerve-hemidiaphragm preparationL L Simpson
Journal of Neurochemistry|February 1, 1972
The use of phospholipase C in the study of receptors for neuromuscular blocking agentsL L Simpson
The American Journal of Psychiatry|November 1, 1979
Combined use of molindone and guanethidine in patients with schizophrenia and hypertensionL L Simpson
Advances in Cytopharmacology|January 1, 1979
Studies on the mechanism of action of botulinum toxinL L Simpson
Biochemical Pharmacology|January 1, 1978
Evidence that deprenyl, A type B monoamine oxidase inhibitor, is an indirectly acting sympathomimetic amineL L Simpson
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1978
Mechanism of the adverse interaction between monoamine oxidase inhibitors and amphetamineL L Simpson
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1975
An analysis of the sympathomimetic activity of 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (TIQ)L L Simpson
Pageof 12